Botox, the first FDA approved treatment for frown lines, revolutionized the nonsurgical options for patients desiring a more youthful facial appearance. Then came Dysport, similar to Botox but offering a slightly faster time to achieve its full affect. Now Xeomin (incobotulinumtoxinA), the newest injectable wrinkle blocker, is approved in the United States.

Xeomin was already FDA approved for treatment of certain medical conditions associated with abnormal neck and eyelid spasms. The new FDA approval is for improvement of the “11’s”or frown lines between the eyebrows. Like Botox and Dysport, Xeomin paralyzes the muscles that cause active wrinkles. And like the other options, the results are not permanent, lasting about 3 to 4 months.

What’s Unique about Xeomin?

  • Since it does not have additives, Xeomin may have less antibody reactions
  • Unlike Dysport, it takes about a week to see the results (more like Botox)
  • It does not need to be refrigerated

The cost of Xeomin is expected to be similar to that of Botox and Dysport.

Although it is likely that Xeomin will become as widely accepted as Botox and Dysport, reasonable care should be taken when considering a treatment session. If you are considering treatment for your wrinkles, it is important to be evaluated by a Board Certified plastic surgeon who is experienced with the delicate anatomy of the facial muscles. Next, you should have a discussion of the options available and know if you are a good candidate for treatment. Having realistic expectations and being aware of limitations is more likely to achieve satisfaction. Finally, you should know about the dramatic improvement that adding facial fillers can have when combined with these wrinkle blocking medications. And as with any other medical procedure, these treatments should only be done by skilled injectors in an appropriate sterile environment such as a medically supervised medi-spa or doctor’s office. Injections should not be done in beauty salons, malls or at parties in the home.

  • Image Source: Ambro / FreeDigitalPhotos.net (Unless otherwise noted, all images are models and not actual patients.)
  • Copyright: Karol A. Gutowski, M.D., Chicago, IL, 2011